Ligand Pharmaceuticals | LGND - Market Capitalization


Ligand Pharmaceuticals reported $5.25B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 189.89B 13.64B Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 8.78B 236M Mar/2026
Baxter International USD 8.67B 1.15B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Enviri Corporation USD 1.45B 423M Dec/2025
Gilead Sciences USD 172.99B 20.71B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Glaxosmithkline GBP 108.55B 736M Jul/2026
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 35.3B 1.82B Mar/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Karyopharm Therapeutics USD 1.12B 989M Jul/2026
Ligand Pharmaceuticals USD 3.98B 241M Mar/2026
MacroGenics USD 287M 103M Jul/2026
Merck USD 297.1B 35.84B Mar/2026
Pacira USD 915M 149M Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Veracyte USD 2.57B 758M Mar/2026